Sg Americas Securities, LLC Iveric Bio, Inc. Transaction History

Sg Americas Securities, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$26.24 - $39.63 $548,809 - $828,861	20,915 New	20,915 $823,000
Q4 2022 Feb 02, 2023	BUY	$17.24 - $23.95 $3.8 Million - $5.27 Million	220,173 Added 1123.16%	239,776 $5.13 Million
Q3 2022 Oct 31, 2022	SELL	$9.4 - $18.59 $1.32 Million - $2.61 Million	-140,471 Reduced 87.75%	19,603 $352,000
Q2 2022 Jul 29, 2022	BUY	$9.12 - $18.9 $1.15 Million - $2.39 Million	126,444 Added 375.99%	160,074 $1.54 Million
Q1 2022 Apr 29, 2022	SELL	$12.15 - $16.83 $26,887 - $37,244	-2,213 Reduced 6.17%	33,630 $566,000
Q4 2021 Feb 07, 2022	SELL	$13.83 - $18.78 $359,040 - $487,547	-25,961 Reduced 42.01%	35,843 $599,000
Q3 2021 Nov 01, 2021	BUY	$7.07 - $17.5 $436,954 - $1.08 Million	61,804 New	61,804 $1 Million
Q2 2021 Aug 12, 2021	SELL	$5.69 - $7.17 $488,526 - $615,594	-85,857 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$5.08 - $6.89 $356,478 - $483,491	70,173 Added 447.42%	85,857 $531,000
Q4 2020 Feb 04, 2021	BUY	$5.65 - $7.66 $88,614 - $120,139	15,684 New	15,684 $108,000
Q3 2020 Nov 09, 2020	SELL	$4.01 - $6.29 $83,339 - $130,725	-20,783 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$3.06 - $6.6 $63,595 - $137,167	20,783 New	20,783 $106,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.